| Drug Class: |
Research-stage metabolic modulator (ERRα/ERRγ agonist pathway-related small-molecule compound) |
| Molecular Formula: |
C24H21ClN2O3 (reported for SLU-PP-332 analogue class) |
| Molecular Weight: |
~420–440 g/mol (reported range depending on salt form) |
| Form: |
Oral tablets |
| Purity: |
Not specified (typically ≥98% for research-grade synthesis) |
| Sequence: |
Not applicable (non-peptide small-molecule compound) |
| Brand: |
Dragon Pharma |
| Substances: |
SLU-PP-332 (metabolic research compound; ERR pathway agonist class) |
| Concentration: |
500 mcg |
Product Disclaimer: Research Purposes Only
This product is intended strictly for laboratory research and in vitro analysis. It is not approved for human or animal use. Any form of internal administration is prohibited by law. Handling should be limited to qualified and licensed professionals. This item is not classified as a pharmaceutical, dietary supplement, or cosmetic product. For educational and scientific research use only.
What is SLU-PP-332 Tablets?
SLU-PP-332 tablets contain SLU-PP-332, an investigational compound classified as a selective Estrogen-Related Receptor (ERR) agonist, primarily targeting ERRα, ERRβ, and ERRγ. Unlike anabolic agents or SARMs, SLU-PP-332 does not interact with androgen receptors; instead, it influences cellular energy metabolism and mitochondrial function. It has gained attention in early-stage research for its potential role as an "exercise mimetic," meaning it may activate metabolic pathways similar to those stimulated during endurance training. Preclinical studies suggest that SLU-PP-332 enhances oxidative metabolism, increases mitochondrial biogenesis, and promotes improved fat utilization. As a tablet formulation, it provides oral bioavailability for controlled experimental protocols. SLU-PP-332 remains strictly a research compound, with no approved medical use and limited human clinical data available.
Mechanism of Action:
SLU-PP-332 functions by activating Estrogen-Related Receptors (ERRs), a group of orphan nuclear receptors involved in regulating genes associated with energy homeostasis, mitochondrial activity, and oxidative phosphorylation. By stimulating ERR signaling pathways, SLU-PP-332 increases the transcription of genes responsible for fatty acid oxidation, glucose metabolism, and mitochondrial enzyme production. This activation enhances cellular energy efficiency and mimics certain adaptations observed in endurance exercise, such as improved metabolic flexibility and increased aerobic capacity. Unlike PPAR agonists or androgen-based compounds, SLU-PP-332 works independently of hormonal pathways and does not affect testosterone levels. Its action is primarily metabolic, targeting skeletal muscle and other energy-demanding tissues. However, as research remains preclinical, the full safety profile and long-term systemic effects are not yet fully characterized.
Benefits:
- Supports mitochondrial biogenesis and oxidative metabolism
- Enhances fatty acid oxidation and metabolic efficiency
- May improve endurance-related physiological markers
- Does not suppress endogenous testosterone or hormonal balance
Research Applications:
- Investigation of exercise mimetic compounds
- Study of metabolic disorders and obesity-related conditions
- Research on mitochondrial dysfunction and energy metabolism
- Exploration of ERR receptor signaling in skeletal muscle physiology
Dosing Instructions:
- Dosing: Administer strictly under structured experimental protocols
- Daily Dose: Evaluated in controlled low milligram research ranges
- Route: Oral administration (tablet form)
- Duration: Short-term preclinical or laboratory-based research cycles
- Frequency: Typically once daily based on pharmacokinetic modeling
- Recommended Cycles: Not approved for recreational or performance use
- PCT: Not required, as it does not impact the HPG axis
Stacking With Other Products:
- Studied alongside PPAR agonists in metabolic research models
- May be evaluated with AMPK activators for synergistic metabolic effects
- Combining with stimulant-based fat loss agents may increase metabolic strain
- Avoid stacking with unregulated experimental compounds outside controlled settings
Side Effects:
- Limited human safety data available
- Potential alterations in metabolic markers
- Unknown long-term cardiovascular impact
- Possible gastrointestinal discomfort in oral studies
Contraindications:
- Pregnancy or breastfeeding
- Individuals with unstable cardiovascular conditions
- Severe metabolic or endocrine disorders
- Participation in regulated competitive sports
Conclusion
SLU-PP-332 tablets represent a novel class of investigational ERR agonists designed to target cellular energy metabolism and mitochondrial function. By activating estrogen-related receptors, this compound may replicate certain metabolic adaptations associated with endurance training, including enhanced oxidative capacity and improved fat utilization. Unlike androgenic or hormonal agents, SLU-PP-332 operates through non-hormonal nuclear receptor pathways and does not suppress testosterone production. However, as research remains in early stages, comprehensive human safety data are lacking. Its classification as a research-only compound underscores the need for further investigation into long-term metabolic, cardiovascular, and systemic effects before any therapeutic considerations can be established.
References:
- Billon C, et al. "Estrogen-Related Receptors and Metabolic Regulation." Endocrine Reviews.
- Rangwala SM, et al. "ERR Signaling in Skeletal Muscle and Energy Homeostasis." Molecular Endocrinology.
- Fan W, et al. "Exercise Mimetics and Mitochondrial Biogenesis Pathways." Cell Metabolism.
- Preclinical Research Publications on SLU-PP-332 and ERR Agonists.

SLU-PP-332 Tablets FAQ:
✔️ What is SLU-PP-332?
SLU-PP-332 is a novel SARM (Selective Androgen Receptor Modulator) that is currently under research. It is believed to have potential benefits for muscle growth, fat loss, and improving overall performance, but more studies are needed for conclusive results.
✔️ How does SLU-PP-332 work?
SLU-PP-332 likely works by binding to androgen receptors in muscle and bone tissue, encouraging an increase in muscle mass and strength. However, as it is a newer compound, its exact mechanisms may still be under investigation.
✔️ What benefits can I expect from SLU-PP-332?
Though limited data is available, SLU-PP-332 is believed to potentially enhance muscle mass, improve strength, and aid in fat loss similar to other SARMs. Its full range of benefits will depend on research results.
✔️ What is the recommended dosage for SLU-PP-332?
Since SLU-PP-332 is not yet widely studied, dosage recommendations can vary. It is important to start with a low dose, such as 5–10 mg per day, and gradually increase while monitoring how your body responds. Always consult with a healthcare professional for precise guidance.
✔️ How long should I use SLU-PP-332?
Typical SARM cycles last between 8–12 weeks, and SLU-PP-332 would likely follow a similar pattern. However, due to limited research, it’s important to follow ongoing scientific updates and consult with a healthcare provider.
✔️ Are there any side effects of SLU-PP-332?
As with other SARMs, potential side effects may include testosterone suppression, water retention, and mood changes. Given that SLU-PP-332 is relatively new, potential side effects may not yet be fully understood, so caution is advised.
SLU-PP-332 Tablets Storage and Safety:
✔️ Storage Conditions:
SLU-PP-332 tablets should be stored in a cool, dry place, ideally at room temperature between 15–30°C (59–86°F). Keep the product away from excessive heat, moisture, and direct sunlight. High temperatures or humidity can degrade the compound, leading to reduced effectiveness or potential safety concerns. Avoid storing the product in bathrooms or other areas with fluctuating temperatures.
✔️ Protect from Light and Air:
Store SLU-PP-332 tablets in their original, tightly sealed container to protect them from light, moisture, and air exposure. These elements can accelerate the breakdown of the compound, compromising its stability. Always make sure the lid is tightly closed after each use to ensure the tablets remain potent and safe.
✔️ Keep Out of Reach of Children:
As with all supplements or research compounds, SLU-PP-332 should be stored securely and out of the reach of children. Accidental ingestion of any SARM or research compound can lead to serious health risks, especially for individuals who are not intended to use the product. Store the tablets in a locked or childproof container for added safety.
✔️ Check Expiration Date:
Before using SLU-PP-332, always check the expiration date to ensure the product is within its effective usage period. Using expired tablets may lead to reduced potency or unpredictable side effects. If the product is expired, dispose of it properly in accordance with local guidelines for pharmaceutical disposal to prevent accidental misuse.
✔️ Follow Dosage Instructions:
It is critical to follow the recommended dosage for SLU-PP-332 as prescribed by a healthcare provider or researcher. Exceeding the recommended dosage could lead to undesirable side effects such as hormone imbalances, joint discomfort, or mood swings. Always consult a healthcare provider before starting a new supplement or compound to ensure proper dosage and avoid health risks.
✔️ Monitor for Side Effects:
Although SLU-PP-332 may offer benefits such as muscle growth or fat loss, it is important to monitor for any adverse reactions, including but not limited to, headaches, water retention, testosterone suppression, or irritability. If any severe side effects occur, discontinue use immediately and seek medical advice. Consider following up with post-cycle therapy (PCT) if necessary to help restore natural hormone production.